Multivisceral surgeries with pancreatoduodenectomy for gastric cancer: immediate and long-term results
- 11 August 2025
- journal article
- abstracts
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 8,p. 30-38
Abstract
Objective. To study the immediate and long-term results of multivisceral surgeries with pancreaticoduodenectomy for gastric cancer. Material and methods. The 1st group included 24 patients who underwent multivisceral surgeries with pancreaticoduodenectomy for gastric cancer with pancreatic head and/or duodenum invasion. The 2nd group included 60 patients with gastric cancer who underwent partial resection of the pancreatic head and/or duodenum rather pancreaticoduodenectomy. Results. ASA class III was observed in 10 (41.7%) out of 24 patients in the 1st group and in 12 (20.0%) out of 60 patients in the 2nd group (p=0.041). In group 2, there were no cases of vein invasion (0 versus 12.5%; p=0.021). In group 1, Clavien-Dindo grade ≥3 complications were more common (10 (41.7%) vs. 14 (23.3%) cases, p=0.005). Moreover, pancreatic fistulas of all classes were more common (9 (37.5%) vs. 9 (15.0%) cases, p=0.023). Median overall survival was 15 and 14 months, respectively. Overall five-year survival was 24.1% (95% CI 7.8—45.2) and 8.2% (95% CI 2.3—18.9%), respectively (p=0.483). Locoregional recurrence was more common in the 2nd group (23 (41.8%) out of 55 vs. 3 (13.6%) out of 23 patients, p=0.018). In the 1st group, median overall survival without adjuvant chemotherapy was 13 months (95% CI 5—17), in the group with adjuvant chemotherapy — 37 months (95% CI 14—64). Overall five-year survival was 7.7% (95% CI 5—29.2) and 50.0% (95% CI 13.7—78.5), respectively (p=0.003). Median overall survival in the 2nd group without adjuvant chemotherapy was 13 months (95% CI 5—17), in the 2nd group with chemotherapy — 17 months (95% CI 12—29; p=0.016). The risk of death in the 2nd group with chemotherapy was lower than in the 1st group without chemotherapy (OR 0.385; 95% CI 0.183—0.809; p=0.012). Multivariate analysis in the 1st group revealed that ASA class 3 negatively affected overall survival (OR 3.04; 95% CI 1.04—8.81; p=0.040). Multivariate analysis after combining both groups established that negative factors of long-term prognosis were female gender (OR 2.47; 95% CI 1.25—4.87; p=0.009), coronary artery disease (OR 3.44; 95% CI 1.16—10.17; p=0.025), locoregional recurrence (OR 2.49; 95% CI 1.13—5.50; p=0.024) and type B pancreatic fistula (OR 2.68; 95% CI 1.070—6.731; p=0.035). Positive factors were multivisceral surgeries with pancreaticoduodenectomy (OR 0.36; 95% CI 0.14—0.86; p=0.023) and adjuvant chemotherapy (OR 0.27; 95% CI 0.13—0.57; p<0.001). Conclusion. Multivisceral surgeries with pancreaticoduodenectomy for gastric cancer with pancreatic and/or duodenal invasion is justified in patients with ASA class 1—2 due to higher probability of adjuvant chemotherapy and better survival.Keywords
This publication has 13 references indexed in Scilit:
- Laparoscopic Versus Open Pancreatoduodenectomy in Patients With Periampullary TumorsAnnals of Surgery, 2022
- Complications of modern pancreaticoduodenectomy: A systematic review and meta-analysisHepatobiliary & Pancreatic Diseases International, 2022
- Retrospective analysis of surgically treated pT4b gastric cancer with pancreatic head invasionWorld Journal of Clinical Cases, 2021
- Safety and Oncological Benefit of Hepatopancreatoduodenectomy for Advanced Extrahepatic Cholangiocarcinoma with Horizontal Tumor Spread: Shinshu University ExperienceAnnals of Surgical Oncology, 2020
- Gastric cancer following pancreaticoduodenectomy: Experience from a high-volume center and review of existing literatureSurgery Open Science, 2020
- Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric CancerBioMed Research International, 2019
- Pancreaticoduodenectomy for locally advanced gastric cancer: Results from a pooled analysisAsian Journal of Surgery, 2019
- Pancreaticoduodenectomy for gastric cancerJournal of Cancer Metastasis and Treatment, 2018
- Systematic review of pancreaticoduodenectomy for locally advanced gastric cancerGastric Cancer, 2011
- PANCREATICODUODENECTOMY FOR LOCALLY ADVANCED STOMACH CANCER: PRELIMINARY RESULTSAnz Journal of Surgery, 2008